Preface
Contributors
PART I FOUNDATIONS
Chapter 1 HCV virology
Nicholas Eyre and Michael Beard
Chapter 2 Laboratory diagnosis of hepatitis C
Scott Bowden
Chapter 3 Pathology and pathogenesis of hepatitis C
David G Bowen, Amany Zekry, Patrick Bertolino, Nicholas A Shackel and Geoffrey W McCaughan
Chapter 4 Natural history of hepatitis C virus infection
Hla-Hla Thein and Gregory Dore
PART II THE EPIDEMIC
Chapter 5 Global epidemiology of hepatitis C
Margaret Hellard, Danielle Horyniak and Campbell Aitken
Chapter 6 Transmission of hepatitis C virus
Libby Topp, Lisa Maher and John Kaldor
PART III RESPONDING TO THE DISEASE IN THE INDIVIDUAL
Chapter 7 Living with hep C: the quest to feel better
Lisa Waller
Chapter 8 Initial assessment and clinical monitoring of people with hepatitis C
Gregory Dore
Chapter 9 Improving quality of life for people with hepatitis C
Stuart Loveday and Gregory Dore
Chapter 10 Therapy decision-making for people with chronic hepatitis C
Gregory Dore
Chapter 11 Antiviral therapy for chronic hepatitis C
Bill Sievert
Chapter 12 Natural therapies and hepatitis C
Ses Salmond and Alan Bensoussan
Chapter 13 Acute hepatitis C infection
Jason Grebely and Gregory Dore
Chapter 14 Treatment and care for injecting drug users
Margaret Hellard, Judy Gold and Rachel Sacks-Davis
Chapter 15 Managing drug dependence in people with hepatitis C
Carolyn Day and Paul Steven Haber
Chapter 16 HIV and hepatitis C co-infection
Gail Matthews and Gregory Dore
Chapter 17 Management of advanced liver disease
Martin W James and Simone I Strasser
PART IV RESPONDING TO THE DISEASE IN THE POPULATION
Chapter 18 The social context of hepatitis C
Meredith Temple-Smith
Chapter 19 Public health strategies for hepatitis C
Robert Batey
Chapter 20 Elements of a coordinated response
Jack Wallace and Meredith Temple-Smith
Chapter 21 The role of the health care team
Jacqui Richmond
Chapter 22 The role of community organisations and peer education
Helen Tyrell and Annie Madden
PART V FUTURE DIRECTIONS IN PREVENTION AND TREATMENT
Chapter 23 Future challenges for hepatitis C
Gregory Dore, Meredith Temple-Smith and Andrew Lloyd
Index
|
